NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
26/02/2026
Voltar para busca
Dado oficial do USPTO
LABSAT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: Estados Unidos
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
17/03/2026
Tipo de marca
Verbal
Classes Nice
5, 9, 10
Data de depósito
20/02/2019
Data de registro
29/10/2019
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/02/2026
Última transação
17/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
707
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
Tolochenaz, CH
Examinador
CAHILL, CLARE GALLAGHER
Localização atual
Historical data usage
Titulares e representantes
Titulares
Lunaphore Technologies SA
Lunaphore Technologies SA
Representantes
Courtney Thompson Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic substancespreparations and agents for medical use; diagnostic reagents and contrast media for medical use; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical use; diagnostic test reagents for medical use; medical diagnostic reagents and assays for testing of body fluids; biotechnological preparations for medical use for the treatment of cancer and metabolic diseases
Classe 9
Scientific apparatus and instrumentselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms; optical apparatus and instrumentsmicroscopesoptical profilersoptical filtersoptical glassesoptical lens sightsoptical scannersoptical readersoptical reflectors; weighing apparatus and instrumentsscales and balances; measuring apparatus and instrumentsinstruments for measuring the quantity of contaminantspollutantsmalignant cells in animalplantmicroorganism cells and tissues; signaling apparatus and instrumentssignal processorssignal splitters for electronic apparatus; measuring and testing machines and instrumentsdigitizers; laboratory apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; microfluidic testing apparatus not for medical use in the form of assay chipsbiological assay chipssample processing chips; microfluidic systemssample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubesreservoirspumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidicsnot for medical use used to diagnose cancer; chipsintegrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chipsmicrochips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatusinstruments and devicescalculating machinescentral processing units and computers for the inputoutputtransmissionstorageprocessing of datain particular scientific and medical data relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing
Classe 10
Medical apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; medical apparatus and instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing using fluid technology; diagnostic apparatus for medical use; microfluidic testing apparatus for medical use for testing biomarker expression levels in cell and tissue samples
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
26/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
23/02/2026
ES71
TEAS SECTION 71 RECEIVED
29/10/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
29/10/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/11/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/10/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
06/10/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/10/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/10/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/10/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/10/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
27/11/2020
GPNX
NOTIFICATION PROCESSED BY IB
16/01/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/12/2019
FIMP
FINAL DISPOSITION PROCESSED
29/12/2019
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
28/11/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
29/10/2019
PUBO
PUBLISHED FOR OPPOSITION
13/08/2019
NPUB
NOTICE OF PUBLICATION
24/07/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2019
MAFR
APPLICATION FILING RECEIPT MAILED
06/07/2019
DOCK
ASSIGNED TO EXAMINER
02/07/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/07/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
29/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
20/06/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LABSAT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.